Developer docs
API playgroundTry for free, no card

Search company profiles

ArcScan

Full company profile

uuid0002u6z

Namestring
ArcScan
Legal namestring
ArcScan, Inc.
Websiteurl
arcscan.com
Company typeenum
Private
Founded yearint
2007
Descriptiontext

ArcScan, Inc. is a private medical technology company founded in 2007 and headquartered in Golden, Colorado, that develops and commercializes the Insight 100, a computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging system for ophthalmic anterior-segment diagnostics. The device's core technology, the proprietary Swept Beam Liquid Interface originally developed at Columbia/Weill University and exclusively licensed to ArcScan, uses a mechanically scanned transducer to image anatomy behind the iris — the so-called "Dark Zone" — that optical modalities such as OCT cannot penetrate, with epithelial mapping accuracy down to 1 micron. Clinical applications include pIOL/ICL sizing for refractive surgery, keratoconus screening, corneal/refractive assessment, glaucoma evaluation (including angle, ciliary body, and MIGS planning), and cataract/IOL planning. The platform comprises the Insight 100 hardware (instrument module, fluidics module, electronics), the Insight software package with DICOM/PACS integration and pre-configured clinical scan sets, and the EyeSeal single-patient sterile disposable interface.

The company sells through a sales-led motion with regional sales managers and a VP of Sales and Marketing engaging ophthalmology clinics, refractive surgery centers, academic institutions, and military hospitals directly, supplemented by industry-conference presence (notably AAO) and channel partners — Lovell Government Services for the US military and Shanghai Haohai Biological Technology together with Hangzhou Aijinglun Technology for China following NMPA approval in May 2024. Revenue is generated through capital-equipment sales of the Insight 100, recurring per-procedure sales of EyeSeal disposables (ordered via a Salesforce-based portal), and bundled clinical training. The company holds 19 patents (with up to 26 issued and pending across sources), has cleared FDA 510(k) and CE mark, and reports an installed base of approximately 70 clinics worldwide.

ArcScan's strategic posture is anchored by a deeply clinical leadership team and board: founder/CMO Dr. Dan Reinstein (London Vision Clinic), chairman Dr. Zhaoxing Dai (Shanghai Meishi Ophthalmic & Optics Research Institute), board director Dr. Robert Lin (IQ Laser Vision, 70,000+ refractive procedures), and CEO J. Erik Giphart, Ph.D. (promoted from VP of Engineering in July 2024). The single disclosed institutional capital event is an $11.15 million Preferred Series B from Shanghai Haohai Biological Technology Ltd. in July 2021, which seeded the China expansion that culminated in NMPA clearance and a China-focused go-to-market structure.

Short descriptiontext

ArcScan develops the Insight 100, a computer-controlled 50 MHz robotic very-high-frequency ultrasound device for ophthalmic anterior-segment imaging behind the iris, serving refractive surgeons, ophthalmology clinics, and military/government eye-care facilities across approximately 70 installed sites worldwide.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGolden, United States
HQ citystring
Golden
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ophthalmic ultrasound imaging, anterior segment imaging, ICL sizing technology, keratoconus screening, robotic medical imaging
Industry3 codes
1Refractive Diagnostics & Biometry (Autorefractors, Keratometers, Topography/Tomography, A-Scan/Optical Biometry)
CodeHLAHAJAAPrimaryNo
2Cataract Surgery Systems & IOLs (Phaco Systems, IOLs, Intraoperative Aberrometry, Viscoelastics)
CodeHLAHAJAHPrimaryNo
3Glaucoma Diagnostics & Surgical Devices (Tonometry, Gonioscopy, MIGS, Drainage Implants, Laser Trabeculoplasty)
CodeHLAHAJAIPrimaryNo
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Ophthalmic Ultrasound Diagnostic Imaging Equipment
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Insight 100 Device Sales
TypeHardware Sales
Description

Sale of the Insight 100 ophthalmic ultrasound imaging device to clinics, hospitals, and academic institutions. The device is a capital equipment purchase requiring in-person sales engagement and installation.

arcscan.com
2EyeSeal Disposable Consumables
TypeHardware Sales
Description

Recurring revenue from sterile, single-patient disposable EyeSeal interfaces used during each scan procedure. Consumables are ordered per-patient through the ordering system.

arcscan.com
3Clinical Services and Training
TypeProfessional Services
Description

Pre-training materials, in-person didactic and hands-on training included with device purchase. Ongoing clinical applications support available.

arcscan.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Insight 100 Device - Quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Capital equipment pricing not publicly disclosed. Contact sales for quote.

arcscan.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Insight 100
Description

The next-generation evolution of the Artemis is a more comfortable, repeatable system for capitalizing on the ability of ultrasound to capture anatomy behind the iris. The Insight 100 is a computer-controlled high-frequency ultrasound device designed to equip ophthalmologists with precise, detailed images of the entire anterior segment of the eye.

arcscan.com
+2 more records
Core offering1 text field

ArcScan develops and commercializes the Insight 100, a computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging system that captures precise, repeatable images of the anterior segment of the eye, including anatomy behind the iris that optical technologies (e.g., OCT) cannot visualize. The platform consists of the Insight 100 hardware (instrument module, fluidics module, electronics unit), the EyeSeal single-patient disposable interface, and the Insight software package, sold as capital equipment to ophthalmology clinics for ICL/pIOL sizing, refractive surgical planning, keratoconus screening, epithelial mapping, glaucoma evaluation, and cataract/IOL planning.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Epithelial mapping accuracy down to 1 micron
+4 more records
Product overview1 text field

ArcScan offers the Insight 100 Platform as a unified ophthalmic imaging system consisting of the Insight 100 hardware device (with robotic probe, fluidics module, and electronics unit), the EyeSeal Disposable (sterile single-patient consumable), and the Insight Software Package. The platform uses very-high-frequency ultrasound technology to image areas of the eye behind the iris that optical technologies cannot penetrate, serving clinical applications including pIOL/ICL sizing, corneal tomography, keratoconus screening, glaucoma management, and cataract IOL planning. The system is installed in approximately 70 clinics worldwide.

Product and service2 records
1Insight 100 Platform
CategoryOphthalmic Diagnostic Imaging Equipment
Description

Computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging device for ophthalmologists and refractive surgeons, providing precise, repeatable imaging of the entire anterior segment of the eye including areas behind the iris. Comprises the ArcScan instrument module, fluidics module, electronics unit, and Insight software. Used for pIOL/ICL sizing, refractive surgical planning, keratoconus screening, epithelial mapping, glaucoma management, and cataract/IOL planning.

2EyeSeal Disposable
CategoryMedical Device Consumable
Description

Sterile, single-patient-use disposable interface designed like a swim goggle and filled with saline solution. Creates a sealed fluid pathway between the patient and the Insight 100 transducer so the transducer never contacts the patient's eye, preventing cross-contamination between patients. Ordered per procedure through ArcScan's Salesforce ordering portal.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Dr. Robert Lin / IQ Laser Vision
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-06-30
Description

Dr. Robert Lin, Founder and CEO of IQ Laser Vision (70,000+ refractive procedures over 25 years), joined ArcScan's Board of Directors in June 2023. His practice utilizes three Insight 100 devices and serves as lead clinical reference. International trainer for SMILE (Zeiss) and EVO ICL (Staar). Brings US and China market expertise to fuel ArcScan's marketplace momentum.

arcscan.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive US partner for military ordering of ArcScan products including Insight 100 and EyeSeal consumables. Handles all government contracting for military customers. Contact: lovellgovt@ Gottlieb & [email protected] or 850.684.1867.

3Hangzhou Aijinglun Technology Co., Ltd.
Strategic tierRegionalTypeChannel Partner/ Reseller/ Distributor
Description

CEO Ying (Harvey) Hou oversees promotion and sales of Insight 100 device in China market as well as advancement of the device's Chinese version. Core responsibilities include R&D, manufacturing, and sales of posterior chamber phakic refractive lenses combined with Insight 100 imaging solutions.

arcscan.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sonomed Escalon manufactures ultrasound biomicroscopy (UBM) devices for ophthalmic anterior segment imaging — directly competing with ArcScan's Insight 100 in the same clinical use cases including glaucoma and IOL sizing. Their VuMax and other UBM systems are the incumbent ultrasound alternative that ArcScan displaces.

TypeDirect peer
Description

Quantel Medical (Lumibird Medical division) produces ophthalmic ultrasound platforms including UBM and B-scan devices for anterior and posterior segment imaging. They compete head-to-head with ArcScan in ICL sizing and glaucoma evaluation use cases.

TypeBroad incumbent
Description

Carl Zeiss Meditec is a dominant incumbent in ophthalmic diagnostics with its IOLMaster optical biometry and Cirrus OCT platforms. While not focused on VHF ultrasound, its IOLMaster is the standard for IOL power calculations, making it the primary non-ultrasound alternative for refractive surgical planning.

TypeBroad incumbent
Description

Heidelberg Engineering manufactures the ANTERION anterior segment OCT and SPECTRALIS imaging platforms, widely used for refractive surgery planning and glaucoma assessment. Their OCT-based approach is the primary optical alternative to ArcScan's ultrasound imaging.

TypeBroad incumbent
Description

Nidek offers a broad portfolio of ophthalmic diagnostic devices including optical biometry (AL-Scan), refractors, and ultrasound A-scan systems used in refractive surgery workflows. They compete in the same clinical applications as ArcScan across multiple geographies.

TypeBroad incumbent
Description

Topcon Healthcare produces OCT, fundus imaging, and biometry systems (including the Aladdin) used in ophthalmic diagnostics and refractive surgery planning. They are a broad incumbent offering overlapping capabilities to ArcScan's anterior segment imaging platform.

TypeBroad incumbent
Description

Tomey Corporation manufactures ophthalmic diagnostic equipment including optical biometry (OA-2000), specular microscopy, and ultrasound devices. Their multi-modality offerings compete in the same refractive surgery and anterior segment imaging workflow as ArcScan.

TypeBroad incumbent
Description

Haag-Streit offers ophthalmic imaging and biometry solutions (including the Lenstar optical biometer) widely used in cataract and refractive surgery clinics. They represent an incumbent alternative in the surgical planning workflow where ArcScan's Insight 100 is positioned.

TypeEmerging player
Description

Icare specializes in ophthalmic diagnostic devices with a primary focus on tonometry (glaucoma screening), and has expanded into broader imaging. Their iCare product line competes in the ophthalmic point-of-care diagnostic space adjacent to ArcScan's clinical applications.

TypeEmerging player
Description

STAAR Surgical manufactures the EVO ICL (Implantable Collamer Lens) — the phakic IOL product whose implantation workflow drives much of ArcScan's ICL sizing demand. While not a direct imaging competitor, STAAR's commercial success directly impacts ArcScan's addressable procedure volumes.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ArcScan

Ophthalmic Ultrasound Diagnostic Imaging Equipmentarcscan.com

ArcScan develops the Insight 100, a computer-controlled 50 MHz robotic very-high-frequency ultrasound device for ophthalmic anterior-segment imaging behind the iris, serving refractive surgeons, ophthalmology clinics, and military/government eye-care facilities across approximately 70 installed sites worldwide.

What ArcScan does

ArcScan, Inc. is a private medical technology company founded in 2007 and headquartered in Golden, Colorado, that develops and commercializes the Insight 100, a computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging system for ophthalmic anterior-segment diagnostics. The device's core technology, the proprietary Swept Beam Liquid Interface originally developed at Columbia/Weill University and exclusively licensed to ArcScan, uses a mechanically scanned transducer to image anatomy behind the iris — the so-called "Dark Zone" — that optical modalities such as OCT cannot penetrate, with epithelial mapping accuracy down to 1 micron. Clinical applications include pIOL/ICL sizing for refractive surgery, keratoconus screening, corneal/refractive assessment, glaucoma evaluation (including angle, ciliary body, and MIGS planning), and cataract/IOL planning. The platform comprises the Insight 100 hardware (instrument module, fluidics module, electronics), the Insight software package with DICOM/PACS integration and pre-configured clinical scan sets, and the EyeSeal single-patient sterile disposable interface.

The company sells through a sales-led motion with regional sales managers and a VP of Sales and Marketing engaging ophthalmology clinics, refractive surgery centers, academic institutions, and military hospitals directly, supplemented by industry-conference presence (notably AAO) and channel partners — Lovell Government Services for the US military and Shanghai Haohai Biological Technology together with Hangzhou Aijinglun Technology for China following NMPA approval in May 2024. Revenue is generated through capital-equipment sales of the Insight 100, recurring per-procedure sales of EyeSeal disposables (ordered via a Salesforce-based portal), and bundled clinical training. The company holds 19 patents (with up to 26 issued and pending across sources), has cleared FDA 510(k) and CE mark, and reports an installed base of approximately 70 clinics worldwide.

ArcScan's strategic posture is anchored by a deeply clinical leadership team and board: founder/CMO Dr. Dan Reinstein (London Vision Clinic), chairman Dr. Zhaoxing Dai (Shanghai Meishi Ophthalmic & Optics Research Institute), board director Dr. Robert Lin (IQ Laser Vision, 70,000+ refractive procedures), and CEO J. Erik Giphart, Ph.D. (promoted from VP of Engineering in July 2024). The single disclosed institutional capital event is an $11.15 million Preferred Series B from Shanghai Haohai Biological Technology Ltd. in July 2021, which seeded the China expansion that culminated in NMPA clearance and a China-focused go-to-market structure.

ArcScan firmographics

Firmographics
Name
ArcScan
Legal name
ArcScan, Inc.
Website
https://arcscan.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
11–50 employees
Short description
ArcScan develops the Insight 100, a computer-controlled 50 MHz robotic very-high-frequency ultrasound device for ophthalmic anterior-segment imaging behind the iris, serving refractive surgeons, ophthalmology clinics, and military/government eye-care facilities across approximately 70 installed sites worldwide.
Ownership category
akta.pro rank

Where ArcScan is headquartered

Location

Headquarters

HQ city
Golden
HQ country
United States
HQ region
North America

Offices1 record

Markets served

ArcScan business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Insight 100 Device Sales: Sale of the Insight 100 ophthalmic ultrasound imaging device to clinics, hospitals, and academic institutions. The device is a capital equipment purchase requiring in-person sales engagement and installation.
  2. EyeSeal Disposable Consumables: Recurring revenue from sterile, single-patient disposable EyeSeal interfaces used during each scan procedure. Consumables are ordered per-patient through the ordering system.
  3. Clinical Services and Training: Pre-training materials, in-person didactic and hands-on training included with device purchase. Ongoing clinical applications support available.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractInsight 100 Device - Quote-based pricing

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

ArcScan product offering

Product offering

Core offering

ArcScan develops and commercializes the Insight 100, a computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging system that captures precise, repeatable images of the anterior segment of the eye, including anatomy behind the iris that optical technologies (e.g., OCT) cannot visualize. The platform consists of the Insight 100 hardware (instrument module, fluidics module, electronics unit), the EyeSeal single-patient disposable interface, and the Insight software package, sold as capital equipment to ophthalmology clinics for ICL/pIOL sizing, refractive surgical planning, keratoconus screening, epithelial mapping, glaucoma evaluation, and cataract/IOL planning.

Product overview

ArcScan offers the Insight 100 Platform as a unified ophthalmic imaging system consisting of the Insight 100 hardware device (with robotic probe, fluidics module, and electronics unit), the EyeSeal Disposable (sterile single-patient consumable), and the Insight Software Package. The platform uses very-high-frequency ultrasound technology to image areas of the eye behind the iris that optical technologies cannot penetrate, serving clinical applications including pIOL/ICL sizing, corneal tomography, keratoconus screening, glaucoma management, and cataract IOL planning. The system is installed in approximately 70 clinics worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • Insight 100: The next-generation evolution of the Artemis is a more comfortable, repeatable system for capitalizing on the ability of ultrasound to capture anatomy behind the iris. The Insight 100 is a computer-controlled high-frequency ultrasound device designed to equip ophthalmologists with precise, detailed images of the entire anterior segment of the eye.
  • EyeSeal
  • Swept Beam Liquid Interface

Products and services

  • Insight 100 Platform Computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging device for ophthalmologists and refractive surgeons, providing precise, repeatable imaging of the entire anterior segment of the eye including areas behind the iris. Comprises the ArcScan instrument module, fluidics module, electronics unit, and Insight software. Used for pIOL/ICL sizing, refractive surgical planning, keratoconus screening, epithelial mapping, glaucoma management, and cataract/IOL planning.
  • EyeSeal Disposable Sterile, single-patient-use disposable interface designed like a swim goggle and filled with saline solution. Creates a sealed fluid pathway between the patient and the Insight 100 transducer so the transducer never contacts the patient's eye, preventing cross-contamination between patients. Ordered per procedure through ArcScan's Salesforce ordering portal.

Quantifiable outcome

  • Epithelial mapping accuracy down to 1 micron
  • +4 more outcomes

Companies that use ArcScan

Customer profile

Named customers9 records

Segments3 records

Ideal customer profiles3 records

ArcScan technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature8 records

ArcScan partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and regional.

  • Dr. Robert Lin / IQ Laser VisioncoreStrategic or Co-development Partner · 30 June 2023Dr. Robert Lin, Founder and CEO of IQ Laser Vision (70,000+ refractive procedures over 25 years), joined ArcScan's Board of Directors in June 2023. His practice utilizes three Insight 100 devices and serves as lead clinical reference. International trainer for SMILE (Zeiss) and EVO ICL (Staar). Brings US and China market expertise to fuel ArcScan's marketplace momentum.
  • Lovell Government ServicescoreChannel Partner/ Reseller/ DistributorExclusive US partner for military ordering of ArcScan products including Insight 100 and EyeSeal consumables. Handles all government contracting for military customers. Contact: lovellgovt@ Gottlieb & [email protected] or 850.684.1867.
  • Hangzhou Aijinglun Technology Co., Ltd.regionalChannel Partner/ Reseller/ DistributorCEO Ying (Harvey) Hou oversees promotion and sales of Insight 100 device in China market as well as advancement of the device's Chinese version. Core responsibilities include R&D, manufacturing, and sales of posterior chamber phakic refractive lenses combined with Insight 100 imaging solutions.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

ArcScan competitors and assessment

Company assessment

Direct peers

  • Sonomed Escalon: Sonomed Escalon manufactures ultrasound biomicroscopy (UBM) devices for ophthalmic anterior segment imaging — directly competing with ArcScan's Insight 100 in the same clinical use cases including glaucoma and IOL sizing. Their VuMax and other UBM systems are the incumbent ultrasound alternative that ArcScan displaces.
  • Quantel Medical: Quantel Medical (Lumibird Medical division) produces ophthalmic ultrasound platforms including UBM and B-scan devices for anterior and posterior segment imaging. They compete head-to-head with ArcScan in ICL sizing and glaucoma evaluation use cases.

Broad incumbents

  • Carl Zeiss Meditec: Carl Zeiss Meditec is a dominant incumbent in ophthalmic diagnostics with its IOLMaster optical biometry and Cirrus OCT platforms. While not focused on VHF ultrasound, its IOLMaster is the standard for IOL power calculations, making it the primary non-ultrasound alternative for refractive surgical planning.
  • Heidelberg Engineering: Heidelberg Engineering manufactures the ANTERION anterior segment OCT and SPECTRALIS imaging platforms, widely used for refractive surgery planning and glaucoma assessment. Their OCT-based approach is the primary optical alternative to ArcScan's ultrasound imaging.
  • Nidek: Nidek offers a broad portfolio of ophthalmic diagnostic devices including optical biometry (AL-Scan), refractors, and ultrasound A-scan systems used in refractive surgery workflows. They compete in the same clinical applications as ArcScan across multiple geographies.
  • Topcon Healthcare: Topcon Healthcare produces OCT, fundus imaging, and biometry systems (including the Aladdin) used in ophthalmic diagnostics and refractive surgery planning. They are a broad incumbent offering overlapping capabilities to ArcScan's anterior segment imaging platform.
  • Tomey Corporation: Tomey Corporation manufactures ophthalmic diagnostic equipment including optical biometry (OA-2000), specular microscopy, and ultrasound devices. Their multi-modality offerings compete in the same refractive surgery and anterior segment imaging workflow as ArcScan.
  • Haag-Streit Group: Haag-Streit offers ophthalmic imaging and biometry solutions (including the Lenstar optical biometer) widely used in cataract and refractive surgery clinics. They represent an incumbent alternative in the surgical planning workflow where ArcScan's Insight 100 is positioned.

Emerging players

  • Icare (Revenio Group): Icare specializes in ophthalmic diagnostic devices with a primary focus on tonometry (glaucoma screening), and has expanded into broader imaging. Their iCare product line competes in the ophthalmic point-of-care diagnostic space adjacent to ArcScan's clinical applications.
  • STAAR Surgical: STAAR Surgical manufactures the EVO ICL (Implantable Collamer Lens) — the phakic IOL product whose implantation workflow drives much of ArcScan's ICL sizing demand. While not a direct imaging competitor, STAAR's commercial success directly impacts ArcScan's addressable procedure volumes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks1 record

Key highlights7 records

Customer concentration

ArcScan social profiles

Digital presence

ArcScan compliance and trust

Trust signal

Compliance3 records

ArcScan financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ArcScan leadership team

Management profile

Number of profiles

Profiles7 records

ArcScan funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ArcScan M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ArcScan

What does ArcScan do?

ArcScan develops and commercializes the Insight 100, a computer-controlled very-high-frequency (50 MHz) robotic ultrasound imaging system that captures precise, repeatable images of the anterior segment of the eye, including anatomy behind the iris that optical technologies (e.g., OCT) cannot visualize. The platform consists of the Insight 100 hardware (instrument module, fluidics module, electronics unit), the EyeSeal single-patient disposable interface, and the Insight software package, sold as capital equipment to ophthalmology clinics for ICL/pIOL sizing, refractive surgical planning, keratoconus screening, epithelial mapping, glaucoma evaluation, and cataract/IOL planning.

Is ArcScan a public or private company?

ArcScan is a private company. It is classified as venture growth investor backed and is currently operating.

When was ArcScan founded?

ArcScan was founded in 2007. It employs 11 to 50 people.

Where is ArcScan based?

ArcScan is headquartered in Golden, United States, in the North America region.

How does ArcScan make money?

Three revenue lines are on record. Insight 100 Device Sales are the primary driver. The others are eyeSeal Disposable Consumables and clinical Services and Training.

Who are ArcScan's main competitors?

Direct peers on record are Sonomed Escalon and Quantel Medical. Broad incumbents are Carl Zeiss Meditec, Heidelberg Engineering, Nidek, Topcon Healthcare, Tomey Corporation and Haag-Streit Group. Emerging players are Icare (Revenio Group) and STAAR Surgical.

Does ArcScan have an API?

No public API is recorded for ArcScan.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireArcScan, Inc. Signs Definitive Agreement for $11.15 Million Preferred Series B Investment with Shanghai Haohai Biological Technology Ltd.ArcScan, Inc., a Colorado-based developer of ophthalmic ultrasound imaging devices, has signed a Stock Purchase Agreement with Shanghai Haohai Biological Technology Ltd. for an $11.15 million Preferred Series B investment. Haohai is a publicly traded Chinese ophthalmology and medical aesthetics company with listings on the Hong Kong and Shanghai stock exchanges. The transaction is described as a strategic fit that will provide ArcScan a base to expand into the Chinese ophthalmology market while complementing Haohai's global product portfolio for implantable lenses.PR NewswireArcScan Adds Ramgopal 'Ram' Rao to Board of DirectorsArcScan, Inc., a Colorado-based ophthalmic visualization technology company, announced the appointment of Ramgopal "Ram" Rao to its board of directors. Rao brings 25 years of ophthalmic industry experience, having founded multiple medical device companies including LensGen, Inc. and held executive positions at various ophthalmic technology firms. His appointment is intended to provide strategic guidance drawing from his background in developing corneal topography imaging and intraocular lens technologies.NewswireArcScan Adds Ramgopal 'Ram' Rao to Board of DirectorsArcScan, Inc. announced the appointment of Ramgopal 'Ram' Rao to its board of directors on October 9, 2019. Rao brings extensive experience from his roles as CEO of LensGen, Inc. and chairman of 2C Tech Corporation, both medical device companies. This addition aims to leverage his background in ophthalmic pharmaceuticals and devices to support ArcScan's strategic direction.GlobeNewswireTilting Capital Corp. Announces Closing of Second Tranche of Debenture Private Placement, Increase of Bridge Loan to ArcScan, Inc. and Extension of ArcScan, Inc. TransactionTilting Capital Corp. closed the second tranche of its debenture private placement, issuing CDN$279,000 of convertible debentures maturing November 30, 2016. The proceeds increased the bridge loan to ArcScan to CDN$649,000 and extended the merger's outside date to January 29, 2016. The transaction remains subject to TSXV acceptance and shareholder approval.